Alex Morgan Khosla

Alex has an MD and PhD in biomedical informatics from Stanford with a dissertation on machine learning methods in precision medicine under the supervision of Atul Butte.

Alex morgan khosla. Series B funding was led by Khosla Ventures with total capital raised now of 70M including support from the US. Alex has a special focus in biotechnology healthcare data science and AIML and serves on the boards of a number of Khosla Ventures portfolio. Alex Morgan genomics_doc is currently a Principal on the investment team at Khosla Ventures a Silicon Valley VC fund which invests broadly in technology from seed stage funding to later stage capital investments where Alex has a special focus on biotechnology healthcare data science and AIML.

Has 16 jobs listed on their profile. See Alex Morgans compensation career history education memberships. Cellino has a unique technique technology for AI-guided laser editing of stem cells for personalized therapies.

UCSF Health Hub HP Betterhelp Avison Young Advsr. The round was co-led by Khosla Ventures and Zetta Venture Partners with. We in general have not focused our investments around products or technology that are very reliant on a particular reimbursement code.

Morgan MD PhDS profile on LinkedIn the worlds largest professional community. Morgan then picked up the thread mentioning that Khosla has a bunch of different companies taking a bunch of different approaches including Gingerio Sword and Hello Heart. Managing Member Neuro Technology Investors.

Alex is a Partner on the investment team at Khosla Ventures where he has a special focus in biotechnology healthcare data science and AIML. Alex Morgan genomicsdoc is currently a Principal on the investment team at Khosla Ventures a Silicon Valley VC fund which invests broadly in technology from seed stage funding to later stage capital investments where Alex focuses on biotechnology healthcare data science and AIML. Alex Morgan Principal at Khosla Ventures and Adam DAugelli Partner at True Ventures have joined Deep Genomics board of directors.

Cellino has a unique technique technology for AI-guided laser editing of stem cells for personalized therapies. We have a number of companies working specifically on COVID-19 in terms of developing new diagnostics or therapeutic approaches. Alex Morgan is a Principal on the investment team at Khosla Ventures with a special focus on biotechnology healthcare data science and AIML.